107 related articles for article (PubMed ID: 7763310)
41. Synthesis and biological evaluation of 2,4,5-substituted pyrimidines as a new class of tubulin polymerization inhibitors.
Xie F; Zhao H; Li D; Chen H; Quan H; Shi X; Lou L; Hu Y
J Med Chem; 2011 May; 54(9):3200-5. PubMed ID: 21480626
[TBL] [Abstract][Full Text] [Related]
42. Antileishmanial activity and tubulin polymerization inhibition of podophyllotoxin derivatives on Leishmania infantum.
Escudero-Martínez JM; Pérez-Pertejo Y; Reguera RM; Castro MÁ; Rojo MV; Santiago C; Abad A; García PA; López-Pérez JL; San Feliciano A; Balaña-Fouce R
Int J Parasitol Drugs Drug Resist; 2017 Dec; 7(3):272-285. PubMed ID: 28719882
[TBL] [Abstract][Full Text] [Related]
43. Topoisomerase I-mediated DNA cleavage as a guide to the development of antitumor agents derived from the marine alkaloid lamellarin D: triester derivatives incorporating amino acid residues.
Tardy C; Facompré M; Laine W; Baldeyrou B; García-Gravalos D; Francesch A; Mateo C; Pastor A; Jiménez JA; Manzanares I; Cuevas C; Bailly C
Bioorg Med Chem; 2004 Apr; 12(7):1697-712. PubMed ID: 15028262
[TBL] [Abstract][Full Text] [Related]
44. New 3-Substituted-2-(4-hydroxyanilino)pyridine Derivatives: Synthesis, Antitumor Activity, and Tubulin Polymerization Inhibition.
Elmeligie S; Khalil NA; Ahmed EM; Emam SH
Arch Pharm (Weinheim); 2017 Feb; 350(2):. PubMed ID: 28150327
[TBL] [Abstract][Full Text] [Related]
45. Novel antitumor indolizino[6,7-b]indoles with multiple modes of action: DNA cross-linking and topoisomerase I and II inhibition.
Chaniyara R; Tala S; Chen CW; Zang X; Kakadiya R; Lin LF; Chen CH; Chien SI; Chou TC; Tsai TH; Lee TC; Shah A; Su TL
J Med Chem; 2013 Feb; 56(4):1544-63. PubMed ID: 23360284
[TBL] [Abstract][Full Text] [Related]
46. Inhibition of DNA topoisomerase II by azaelliptitoxins functionalized in the variable substituent domain.
Tepe JJ; Madalengoitia JS; Slunt KM; Werbovetz KW; Spoors PG; Macdonald TL
J Med Chem; 1996 May; 39(11):2188-96. PubMed ID: 8667362
[TBL] [Abstract][Full Text] [Related]
47. Synthesis and evaluation of new 2-chloro-4-aminopyrimidine and 2,6-dimethyl-4-aminopyrimidine derivatives as tubulin polymerization inhibitors.
Xu S; An B; Li Y; Luo X; Li X; Jia X
Bioorg Med Chem Lett; 2018 Jun; 28(10):1769-1775. PubMed ID: 29673981
[TBL] [Abstract][Full Text] [Related]
48. Antitumor agents. 174. 2',3',4',5,6,7-Substituted 2-phenyl-1,8-naphthyridin-4-ones: their synthesis, cytotoxicity, and inhibition of tubulin polymerization.
Chen K; Kuo SC; Hsieh MC; Mauger A; Lin CM; Hamel E; Lee KH
J Med Chem; 1997 Jul; 40(14):2266-75. PubMed ID: 9216846
[TBL] [Abstract][Full Text] [Related]
49. Molecular modelling studies on Arylthioindoles as potent inhibitors of tubulin polymerization.
Coluccia A; Sabbadin D; Brancale A
Eur J Med Chem; 2011 Aug; 46(8):3519-25. PubMed ID: 21621885
[TBL] [Abstract][Full Text] [Related]
50. Podophyllotoxin analogs: effects on DNA topoisomerase II, tubulin polymerization, human tumor KB cells, and their VP-16-resistant variants.
Liu SY; Hwang BD; Haruna M; Imakura Y; Lee KH; Cheng YC
Mol Pharmacol; 1989 Jul; 36(1):78-82. PubMed ID: 2546053
[TBL] [Abstract][Full Text] [Related]
51. Design, synthesis, biological evaluation, and 3D-QSAR analysis of podophyllotoxin-dioxazole combination as tubulin targeting anticancer agents.
Wang ZZ; Sun WX; Wang X; Zhang YH; Qiu HY; Qi JL; Pang YJ; Lu GH; Wang XM; Yu FG; Yang YH
Chem Biol Drug Des; 2017 Aug; 90(2):236-243. PubMed ID: 28079286
[TBL] [Abstract][Full Text] [Related]
52. Design, synthesis, biological evaluation and cocrystal structures with tubulin of chiral β-lactam bridged combretastatin A-4 analogues as potent antitumor agents.
Zhou P; Liang Y; Zhang H; Jiang H; Feng K; Xu P; Wang J; Wang X; Ding K; Luo C; Liu M; Wang Y
Eur J Med Chem; 2018 Jan; 144():817-842. PubMed ID: 29306206
[TBL] [Abstract][Full Text] [Related]
53. A class of novel tubulin polymerization inhibitors exert effective anti-tumor activity via mitotic catastrophe.
Zhang YL; Li BY; Yang R; Xia LY; Fan AL; Chu YC; Wang LJ; Wang ZC; Jiang AQ; Zhu HL
Eur J Med Chem; 2019 Feb; 163():896-910. PubMed ID: 30580241
[TBL] [Abstract][Full Text] [Related]
54. Arylthioindole inhibitors of tubulin polymerization. 3. Biological evaluation, structure-activity relationships and molecular modeling studies.
La Regina G; Edler MC; Brancale A; Kandil S; Coluccia A; Piscitelli F; Hamel E; De Martino G; Matesanz R; Díaz JF; Scovassi AI; Prosperi E; Lavecchia A; Novellino E; Artico M; Silvestri R
J Med Chem; 2007 Jun; 50(12):2865-74. PubMed ID: 17497841
[TBL] [Abstract][Full Text] [Related]
55. (E)-N-Aryl-2-oxo-2-(3,4,5-trimethoxyphenyl)acetohydrazonoyl cyanides as tubulin polymerization inhibitors: Structure-based bioisosterism design, synthesis, biological evaluation, molecular docking and in silico ADME prediction.
Wang G; Peng Z; Peng S; Qiu J; Li Y; Lan Y
Bioorg Med Chem Lett; 2018 Nov; 28(20):3350-3355. PubMed ID: 30197030
[TBL] [Abstract][Full Text] [Related]
56. Substitution at the indole 3 position yields highly potent indolecombretastatins against human tumor cells.
Álvarez R; Gajate C; Puebla P; Mollinedo F; Medarde M; Peláez R
Eur J Med Chem; 2018 Oct; 158():167-183. PubMed ID: 30216850
[TBL] [Abstract][Full Text] [Related]
57. Indole molecules as inhibitors of tubulin polymerization: potential new anticancer agents, an update (2013-2015).
Patil R; Patil SA; Beaman KD; Patil SA
Future Med Chem; 2016 Jul; 8(11):1291-316. PubMed ID: 27476704
[TBL] [Abstract][Full Text] [Related]
58. Synthesis and biological activity of 2,4-di-p-phenolyl-6-2-furanyl-pyridine as a potent topoisomerase II poison.
Karki R; Park C; Jun KY; Kadayat TM; Lee ES; Kwon Y
Eur J Med Chem; 2015 Jan; 90():360-78. PubMed ID: 25437622
[TBL] [Abstract][Full Text] [Related]
59. A Potent, Metabolically Stable Tubulin Inhibitor Targets the Colchicine Binding Site and Overcomes Taxane Resistance.
Arnst KE; Wang Y; Hwang DJ; Xue Y; Costello T; Hamilton D; Chen Q; Yang J; Park F; Dalton JT; Miller DD; Li W
Cancer Res; 2018 Jan; 78(1):265-277. PubMed ID: 29180476
[TBL] [Abstract][Full Text] [Related]
60. Design, synthesis and screening of 1, 2, 4-triazinone derivatives as potential antitumor agents with apoptosis inducing activity on MCF-7 breast cancer cell line.
Zaki I; Abdelhameid MK; El-Deen IM; Abdel Wahab AHA; Ashmawy AM; Mohamed KO
Eur J Med Chem; 2018 Aug; 156():563-579. PubMed ID: 30025350
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
